The relation between plasma leptin concentration and body fat mass in patients with rheumatoid arthritis;Zależność pomiȩdzy stȩżeniem leptyny w surowicy krwi a masa̧ tkanki tłuszczowej u chorych na reumatoidalne zapalenie stawów

Polskie Archiwum Medycyny Wewnetrznej

Volumn 108, Issue 2, 2002, Pages 761-767

  Tokarczyk Knapik, Anita ^a,b   Nowicki, Michal ^a   Wyroślak, Janusz ^a  

^a Klinika Nefrologii Dializoterapii I

^b Poradnia Reumatologiczna SP ZLA K ^*

Author keywords

Chronic inflammation; Fat tissue; Leptin; Rheumatoid arthritis

Indexed keywords

LEPTIN;

AGED; ARTICLE; BLOOD; BODY COMPOSITION; BODY MASS; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RHEUMATOID ARTHRITIS; RISK FACTOR; WEIGHT REDUCTION;

AGED; ARTHRITIS, RHEUMATOID; BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; WEIGHT LOSS;

EID: 0036676633     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Filipowicz-Sosnowska A., Stanisławska-Biernat E., Zubrzycka-Sienkiewicz A.: Standardy diagnostyczno-terapeutyczne w najczȩstszych chorobach reumatycznych. Reumatoidalne zapalenie stawów. Reumatologia 2000, 38 (suppl.), 7.
2. Chwalińska-Sadowska H.: Reumatologia kliniczna, CMKP, Warszawa, 1995.
3. Monro R., Capell H.: Prevalence of low body mass in rheumatoid arthritis. Association with the acute phase response. Ann. Rheum. Dis., 1997, 56, 326.
4. Roubenoff R., Roubenoff R.A., Cannon J.H. i wsp.: Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J. Clin. Invest., 1994, 93, 2379.
5. Filipowicz-Sosnowska A., Za̧bek J.: Reumatologia. Naukowe podstawy chorób reumatycznych. MKSAP, Warszawa, 1997.
6. Holden R.J., Pakula I.S.: The role of tumor necrosis factor - alpha in the pathogenesis of anorexia and bulimia nervosa, cachexia and obesity. Med. Hypotheses, 1996, 47, 423.
7. Auwerx J., Staels B.: Leptin. Lancet, 1998, 351, 737.
8. 3-adrenergic receptor in adipose tissue. Am. J. Physiol., 1998, 274, E992.
9. Chudek J., Kokot F.: Leptyna - hormon sytości. Pol. Arch. Med. Wewn., 1996, 95, 397.
10. Zhang Y., Proenca R., Maffei M. i wsp.: Positional cloning of the mouse obesity gene and its human homologue. Nature, 1994, 372, 425.
11. Schwartz M.W., Seeley R.J.: Neuroendocrine responses to starvation and weight loss. N. Engl. J. Med., 1997, 336, 1802.
12. Anders HJ., Rihl M., Heufelder A., Loch O., Schattenkircher M.: Leptin serum levels are not correlated with disease activity in patients with rheumatoid arthritis. Metabolism, 1999, 48, 745.
13. Sarraf P., Frederich R.C., Turner E.M. i wsp.: Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J. Exp. Med., 1997, 185, 171.
14. Arnett F.C., Edworthy S.M., Bloch D.A. i wsp.: The American Rheumatism Association 1987. Revisited criteria for the classification of rheumatoid arthritis. Arthritis Rheum., 1988, 31, 315.
15. Prevoo M.L.L., vaut Hof M.A., Kuper H.H., van Leeuven M.A., van de Putte L.B., van Riel P.L.C.M.: Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum., 1995, 38, 44.
16. Piet L.C.M., van Riel A.M., van Gestel M.: The original DAS and the DAS 28 are not interchangeable. Arthritis Rheum., 1998, 41, 942.
17. Nowicki M., Bryc W., Kokot F.: Hormonal regulation of appetite and body mass in patients with advanced prostate cancer treated with combined androgen blockade. J. Endocrinol. Invest, 2001, 24, 31.
18. Sokka T., Kankainen A., Hannonen P.: Scores for functional disability in patients with rheumatoid arthritis are correlated at higher levels with pain scores than with radiographic scores. Arthritis. Rheum., 2000, 43, 386.
19. Wallace A.M., Sattar N., McMillan D.C.: Effect of weight loss and the inflammatory response on leptin concentrations in gastrointestinal cancer patients. Clin. Cancer Res., 1998, 4, 2977.
20. Hoppin A.G., Kaplan L.M., Zurakowski D. i wsp.: Serum leptin in children and young adults with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr., 1998, 26, 500.
21. Kalra S.P., Dube M.G., Pu S. i wsp.: Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocrine Rev., 1999, 20, 68.
22. Milewicz A., Mikulski E., Bidzińska B.: Plasma insulin, cholecystokinin, galanin, neuropeptide Y and leptin levels in obese women with and without type 2 diabetes mellitus. Int. J. Obes. Relat. Metab. Disord., 2000, 24 suppl. 2, S152.
23. Kokot F., Adamczak M., Wiȩcek A., Spiechowicz U., Mesjasz J.: Plasma immunoreactive leptin and neuropeptide Y levels in kidney transplant patients. Am. J. Nephrol., 1999, 19, 28.
24. Cizza G., Lotsikas A.J., Licinio J. i wsp.: Plasma leptin levels do not change in patients with Cushing's disease shortly after correction of hypercortisolism. J. Clin. Endocrinol. Metab., 1997, 82, 2747.
25. Bryc W., Nowicki M., Adamkiewicz A.: Leptyna - ogniwo ła̧cza̧ce gospodarkȩ energetyczna̧ z funkcja̧ gonadalna̧. Endokrynol. Pol. - Polish. J. Endocrinol., 2000, 51, 429.
26. Baumgartner R.N., Waters D.L., Morley J.E., Patrick P., Montoya G.D., Garry P.J.: Age-related changes in sex hormones affect the sex difference in serum leptin independently of changes in body fat metabolism. 1999, 48, 378.
27. Grunfeld C., Pang M., Shigenage J.K. i wsp.: Serum leptin levels in the acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab., 1996, 81, 4342.
28. Lagiou P., Signorello L.B., Trichopoulos D., Tzonou A., Trichopoulou A., Mantzoros C.S.: Leptin in relation to prostate cancer and bening prostatic hyperplasia. Int. J. Cancer, 1998, 76, 25.
29. Grrinspoon S., Gulick T., Askari H. i wsp.: Serum leptin in women with anorexia nervosa. J. Clin. Endocrinol. Metab., 1996, 81, 3861.